Several studies have shown that MEK/ERK is an up-stream kinase that phosphorylates PPARγ at Ser112 [34], which suggests potentially increased activity of MEK/ERK in HCC. This evidence concerns the gene MAP2K7 and hepatocellular carcinoma.